Compare
5 stocks, side by sideRelative performance · rebased to 100
INVAAKTSABSIBCAXANAB
| INVAInnoviva, Inc. | AKTSAktis Oncology, Inc. | ABSIAbsci Corporation | BCAXBicara Therapeutics Inc. | ANABAnaptysBio, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 7/10 | - | 6/10 | 7/10 | 7/10 |
| Price | $21.34 | $24.98 | $8.91 | $23.73 | $56.63 |
| 1 month | +1.1% | +6.4% | +7.4% | -14% | +3.3% |
| 1 year | +2.7% | - | +215% | +107% | +324% |
| 5 year | +40% | - | -63% | - | +267% |
| P/E (TTM) | 3.4 | - | -10.9 | -8.6 | -55.5 |
| P/E vs sector | -89% | - | - | - | - |
| Market cap | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.